NO20030813L - Bifenylderivater og deres anvendelse som integrininhibitorer - Google Patents
Bifenylderivater og deres anvendelse som integrininhibitorerInfo
- Publication number
- NO20030813L NO20030813L NO20030813A NO20030813A NO20030813L NO 20030813 L NO20030813 L NO 20030813L NO 20030813 A NO20030813 A NO 20030813A NO 20030813 A NO20030813 A NO 20030813A NO 20030813 L NO20030813 L NO 20030813L
- Authority
- NO
- Norway
- Prior art keywords
- biphenyl derivatives
- integrin inhibitors
- integrin
- inhibitors
- biphenyl
- Prior art date
Links
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000006495 integrins Human genes 0.000 title 1
- 108010044426 integrins Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10041423A DE10041423A1 (de) | 2000-08-23 | 2000-08-23 | Biphenylderivate |
| PCT/EP2001/008970 WO2002016328A1 (de) | 2000-08-23 | 2001-08-02 | Biphenylderivate und ihre verwendung als integrininhibitoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030813D0 NO20030813D0 (no) | 2003-02-21 |
| NO20030813L true NO20030813L (no) | 2003-02-21 |
Family
ID=7653540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030813A NO20030813L (no) | 2000-08-23 | 2003-02-21 | Bifenylderivater og deres anvendelse som integrininhibitorer |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040010023A1 (no) |
| EP (1) | EP1311489A1 (no) |
| JP (1) | JP2004524264A (no) |
| KR (1) | KR20030022418A (no) |
| CN (1) | CN1447799A (no) |
| AU (1) | AU2001277561A1 (no) |
| BR (1) | BR0113374A (no) |
| CA (1) | CA2420208A1 (no) |
| CZ (1) | CZ2003671A3 (no) |
| DE (1) | DE10041423A1 (no) |
| HU (1) | HUP0301784A3 (no) |
| MX (1) | MXPA03001557A (no) |
| NO (1) | NO20030813L (no) |
| PL (1) | PL359668A1 (no) |
| SK (1) | SK2962003A3 (no) |
| WO (1) | WO2002016328A1 (no) |
| ZA (1) | ZA200302256B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10112771A1 (de) * | 2001-03-16 | 2002-09-26 | Merck Patent Gmbh | Inhibitoren des Integrins alpha¶v¶beta¶6¶ |
| DE10127041A1 (de) * | 2001-06-02 | 2002-12-05 | Merck Patent Gmbh | Integrinantagonisten |
| HRP20130782T1 (en) * | 2004-04-02 | 2013-09-30 | The Regents Of The University Of California, Office Of Technology Transfer | Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin |
| EP2456460A4 (en) | 2009-07-24 | 2013-02-20 | Univ California | METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASES ASSOCIATED WITH AVB5 INTEGRIN |
| EP3589285A4 (en) | 2017-02-28 | 2020-08-12 | Morphic Therapeutic, Inc. | INHIBITORS OF INTEGRIN (ALPHA-V) (BETA-6) |
| CN116283977A (zh) | 2017-02-28 | 2023-06-23 | 莫菲克医疗股份有限公司 | αvβ6整合蛋白的抑制剂 |
| EP3773573A4 (en) | 2018-04-12 | 2022-04-06 | Morphic Therapeutic, Inc. | ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4) (BETA7) |
| SG11202101913PA (en) | 2018-08-29 | 2021-03-30 | Morphic Therapeutic Inc | INHIBITING aV ß6 INTEGRIN |
| RS66976B1 (sr) | 2019-10-16 | 2025-07-31 | Morphic Therapeutic Inc | Inhibiranje ljudskog integrina alfa4beta7 |
| CN120309684A (zh) * | 2024-01-15 | 2025-07-15 | 武汉人福创新药物研发中心有限公司 | 靶向化合物及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU713676B2 (en) * | 1996-01-16 | 1999-12-09 | Merck & Co., Inc. | Integrin receptor antagonists |
| EP1034164B1 (en) * | 1997-11-24 | 2004-05-19 | Merck & Co., Inc. | Substituted beta-alanine derivatives as cell adhesion inhibitors |
| PL350057A1 (en) * | 1999-02-20 | 2002-11-04 | Merck Patent Gmbh | β-ALANINE DERIVATIVES |
-
2000
- 2000-08-23 DE DE10041423A patent/DE10041423A1/de not_active Withdrawn
-
2001
- 2001-08-02 WO PCT/EP2001/008970 patent/WO2002016328A1/de not_active Ceased
- 2001-08-02 CN CN01814416A patent/CN1447799A/zh active Pending
- 2001-08-02 CA CA002420208A patent/CA2420208A1/en not_active Abandoned
- 2001-08-02 US US10/362,234 patent/US20040010023A1/en not_active Abandoned
- 2001-08-02 EP EP01955384A patent/EP1311489A1/de not_active Withdrawn
- 2001-08-02 PL PL01359668A patent/PL359668A1/xx unknown
- 2001-08-02 BR BR0113374-8A patent/BR0113374A/pt not_active Application Discontinuation
- 2001-08-02 AU AU2001277561A patent/AU2001277561A1/en not_active Abandoned
- 2001-08-02 HU HU0301784A patent/HUP0301784A3/hu unknown
- 2001-08-02 JP JP2002521429A patent/JP2004524264A/ja active Pending
- 2001-08-02 CZ CZ2003671A patent/CZ2003671A3/cs unknown
- 2001-08-02 MX MXPA03001557A patent/MXPA03001557A/es unknown
- 2001-08-02 SK SK296-2003A patent/SK2962003A3/sk unknown
- 2001-08-02 KR KR10-2003-7002577A patent/KR20030022418A/ko not_active Withdrawn
-
2003
- 2003-02-21 NO NO20030813A patent/NO20030813L/no unknown
- 2003-03-20 ZA ZA200302256A patent/ZA200302256B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1447799A (zh) | 2003-10-08 |
| KR20030022418A (ko) | 2003-03-15 |
| NO20030813D0 (no) | 2003-02-21 |
| US20040010023A1 (en) | 2004-01-15 |
| HUP0301784A2 (hu) | 2003-12-29 |
| JP2004524264A (ja) | 2004-08-12 |
| CZ2003671A3 (cs) | 2003-06-18 |
| SK2962003A3 (en) | 2003-06-03 |
| PL359668A1 (en) | 2004-08-23 |
| HUP0301784A3 (en) | 2004-03-29 |
| AU2001277561A1 (en) | 2002-03-04 |
| EP1311489A1 (de) | 2003-05-21 |
| WO2002016328A1 (de) | 2002-02-28 |
| ZA200302256B (en) | 2004-07-26 |
| DE10041423A1 (de) | 2002-03-07 |
| BR0113374A (pt) | 2003-07-08 |
| MXPA03001557A (es) | 2003-06-06 |
| CA2420208A1 (en) | 2003-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20026010D0 (no) | Substituerte quinazolinderivater og deres anvendelse som inhibitorer | |
| DK1498413T3 (da) | 4-aminopicolinater og deres anvendelse som herbicider | |
| DK1133477T3 (da) | Substituerede benzimidazoler og deres anvendelse som parpinhibitorer | |
| IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
| NO20025357L (no) | Antranylamider og deres anvendelse som legemidler | |
| NO20031952L (no) | 3-aroylinderivater og deres anvendelse som CB2 reseptoragonister | |
| DK1282611T3 (da) | Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer | |
| DK1480962T3 (da) | 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer | |
| DK1347955T3 (da) | Nye mandelsyrederivater og deres anvendelse som throbin-hæmmere | |
| NO20042719L (no) | Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer | |
| NO20032830D0 (no) | Tetrahydropyridinderivater, fremstilling derav og anvendelse som celle-proliferasjonsinhibitorer | |
| NO20025150D0 (no) | 2-acylindolderivater og deres anvendelse som antitumormidler | |
| DK1170288T3 (da) | Diphenylurinstofderivater og deres anvendelse som alfa2/5-HT2c-antagonister | |
| DK1150996T3 (da) | Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer | |
| DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler | |
| NO20025504D0 (no) | Nye tiokromanderivater og anvendelse derav som trombininhibitorer | |
| NO20030813D0 (no) | Bifenylderivater og deres anvendelse som integrininhibitorer | |
| DK1265892T3 (da) | Isothiazolderivater og deres anvendelse som pesticider | |
| NO20026164L (no) | Benzoksazepinoner og deres anvendelse som squalen syntase inhibitorer | |
| NO20030243L (no) | Nye forbindelser og deres anvendelse som glysintransportinhibitorer | |
| NO20030998D0 (no) | Arylpiperazinderivater og deres anvendelse som psykotropiske midler | |
| NO20023951D0 (no) | Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler | |
| DK1343764T3 (da) | Urinstof og urethanderivater som integrininhibitorer | |
| DK1259515T3 (da) | Thienopyridinderivater og deres anvendelse som antiinflammatoriske midler | |
| NO20025884D0 (no) | 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer |